Requests To Reopen Medicare ESA Policy Are Not Yet Persuasive To CMS
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency advises stakeholders that they must present new data or analysis that current data was materially misinterpreted in order to gain a reconsideration of the erythropoeisis-stimulating agents coverage policy.